-
Achieving the desired end goal: Best approaches to achieving Policy 0070 compliance - new article from
@kinapseglobal 's Pooja Phogat published here in European Pharmaceutical Manufacturer https://buff.ly/2sO9Ydb@EPM_Magazine#policy0070 pic.twitter.com/BAmtOYNz5N
-
Have you heard that
#Policy0070 redaction packages were suspended by the EMA? Learn more in this "ask the expert" feature: http://www.mmsholdings.com/mms-blog/ask-the-expert-policy-0070-redaction-packages-suspended-by-ema-until-2019/ … -
Anne-Sophie Henry-Eude from the
@EMA_News speaks on#Policy0070 and the types of published documents at the@DrugInfoAssn#clinicaltrialtransparency event!pic.twitter.com/slkm1LrscG – mjesto: DoubleTree by Hilton Hotel London - Docklands Riverside
-
Limited spots left in our December 1 webinar: Balancing Utility and Privacy in
#EMA#Policy0070 Submissions: https://goo.gl/ZF7LrZ -
Reserve your place at our latest
#Webinar, and learn the streamlined way to create#EMA#Policy0070 submission-ready packages.#clinicaltrialdisclosure Thursday, July 26th 3pm UK | 4pm CET | 10 am EST Follow the link below to book your place: https://buff.ly/2Jy2tMS pic.twitter.com/aT94OGXqO8
-
May 25 10 AM EDT webinar, Updates on the Implementation of Clinical Trials
#DataSharing:#Policy0070 and Beyond: https://goo.gl/wzLpTq -
Avoiding
#Policy0070 pitfalls, ensuring compliance, and keeping teams engaged within the changing paradigm is challenging but critical to success. Read our blog post to learn more: https://wp.me/p9rwl0-3bU pic.twitter.com/EylZohnVVz
-
Here's a great infographic on how to achieve EMA Policy 0070 from
@kinapseglobal http://ow.ly/btYD30iPKPE#policy0070 pic.twitter.com/UMoUHGNPkh
-
Kniola was part of the
#EMA group working on#Policy0070, and said that once it’s revived, the@EMA_News will be working through its backlog of letters to be issued first, before moving on to new letters. CC:@CBI_Conferences#BeTransparent -
EMA Policy 0070: 5 ways to balance patient privacy with better data utility. Via
@PharmaIQ http://ow.ly/Jayc30jYYFI by Pooja Phogat@KinapseGlobal#Policy0070 -
Want to learn more about achieving
#EMA#Policy0070 compliance? Download our case study, Avoiding Policy 0070 Pitfalls: http://globalsubmit.com/education/white-papers/policy-0070 … -
Learn experiences gained with risk-based anonymization methods when applied to
#Policy0070 submissions: https://goo.gl/SwYDTR -
If you are dealing with
#Policy0070 you will not want to miss this Webinair. Shoot me a DM with any questions.#EMA#clinicaltrialdisclosurehttps://twitter.com/kinapseglobal/status/1019588077348704256 …
-
Helle Ainsworth
@novonordisk talked on#EMA#Policy0070 this morning at#Global#eCTD Management spurring engaging discussion -#eRegulatorypic.twitter.com/42lgqJinnj
-
Initiating a d-Wise
#Blur Advisory Group of our top dozen transparency customers. Send me a note if you are interested in joining.#transparency#policy0070 https://lnkd.in/exvAHzF https://lnkd.in/eAdXp6i -
Protecting Patient Privacy – the most effective approaches to compliance via
@PMLiVEcom http://ow.ly/t5yw30ktA6D P36/37#Policy0070#PatientPrivacy@kinapseglobal -
Best practice strategy to address compliance with EMA policy 0070 via
@Clin_Trials#compliance#clinicaltrials#lifesciences@kinapseglobal#Policy0070 http://ow.ly/S14430j3KeV -
#EREGULATORY,#eCTD,#policy0070 Want to learn more? Check http://spr.ly/6011DHpgD pic.twitter.com/S0VSx90sL4
-
Synchrogenix offers expert guidance & the industry's only
#AI technology platform ensuring consistent#redaction packages. View our new video to learn more about our#Policy0070 solutions and how we can help ensure your company is compliant: https://tinyurl.com/y9rrvcgd pic.twitter.com/uxgOVyCS79
-
Join
@novonordisk for the latest updates on#EMA#Policy0070 publication & access to#clinicaltrial data - https://goo.gl/wLv3eB#eCTD
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.